Approval · Notice of Compliance 95 · 2004
CORTIFOAM: Notice of Compliance 95
Issued January 27, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 95
- Date
- January 27, 2004
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Rectal anti-inflammatory corticosteroid foam
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CORTIFOAM | 00579335 | Cancelled Post Market |
Medicinal ingredients
- HYDROCORTISONE ACETATE 10 PER